Norepinephrine and impulsivity: Effects of acute yohimbine

Psychopharmacology

Volumn 229, Issue 1, 2013, Pages 83-94

  Swann, Alan C ^a   Lijffijt, Marijn ^a   Lane, Scott D ^a   Cox, Blake ^a   Steinberg, Joel L ^a   Moeller, F Gerard ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Alpha; Blood pressure; Continuous performance test; Impulsive behavior; Noradrenergic; Norepinephrine; Receptors; Yohimbine

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; ALPHA 2 ADRENERGIC RECEPTOR; HOMOVANILLIC ACID; NORADRENALIN; PLACEBO; VANILMANDELIC ACID; YOHIMBINE;

ADRENERGIC STIMULATION; ADULT; AGE; ARTICLE; ATTENTION; AUTONOMIC NERVOUS SYSTEM; BEHAVIORAL SCIENCE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EDUCATIONAL STATUS; ELECTROCHEMICAL ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; IMPULSIVENESS; MALE; METABOLITE; NORADRENALIN RELEASE; NORMAL HUMAN; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; RAPID RESPONSE IMPULSIVITY; REACTION TIME; RECEPTOR BLOCKING; SHORT TERM MEMORY; SYSTOLIC BLOOD PRESSURE; TASK PERFORMANCE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ADULT; BLOOD PRESSURE; CATECHOLAMINES; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; NOREPINEPHRINE; REACTION TIME; YOHIMBINE; YOUNG ADULT;

EID: 84881610503     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3088-7     Document Type: Article

References (80)

1. Aghajanian GK (1978) Feedback regulation of central monoaminergic neurons: evidence from single cell recording studies. Essays Neurochem Neuropharmacol 3:1-32
2. Albus M, Zahn TP, Breier A (1992) Anxiogenic properties of yohimbine. II. Influence of experimental set and setting. Eur Arch Psychiatry Clin Neurosci 241:345-351
3. Arnsten AF (2000) Stress impairs prefrontal cortical function in rats and monkeys: role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms. Prog Brain Res 126:183-192
4. Arnsten AF, Dudley AG (2005) Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder. Behav Brain Funct 1:2
5. Arnsten AF, Li BM (2005) Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57:1377-1384
6. Arnsten AF, Pliszka SR (2011) Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders. Pharmacol Biochem Behav 99:211-216
7. Arnsten AF, Mathew R, Ubriani R, Taylor JR, Li BM (1999) Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function. Biol Psychiatry 45:26-31
8. Aston-Jones G, Cohen JD (2005) Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance. J Comp Neurol 493:99-110
9. Avery RA, Franowicz JS, Studholme C, van Dyck CH, Arnsten AF (2000) The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task. Neuropsychopharmacology 23:240-249
10. Baker NJ, Adler LE, Waldo M, Gerhardt G, Drebing C, Cox B, Berry S, Phillips W, Freedman R (1988) Reproducibility of the measurement of plasma noradrenergic and dopaminergic metabolites in normal subjects. Psychiatry Res 23:119-130
11. Bari A, Aston-Jones G (2013) Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons. Neuropharmacology 64:53-64
12. Barratt ES (1985) Impulsiveness subtraits: arousal and information processing. In: Spence JT, Izard CE (eds) Motivation, emotion, and personality. Elsevier Science, Amsterdam, pp 137-146
13. Bauer MS, Crits Christoph P, Ball WA, Dewees E, McAllister T, Alahi P, Cacciola J, Whybrow PC (1991) Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of mania. Arch Gen Psychiatry 48:807-812
14. Baumann MH, Milchanowski AB, Rothman RB (2004) Evidence for alterations in alpha2-adrenergic receptor sensitivity in rats exposed to repeated cocaine administration. Neuroscience 125:683-690
15. Berridge CW, Waterhouse BD (2003) The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42:33-84
16. Birnbaum S, Gobeske KT, Auerbach J, Taylor JR, Arnsten AF (1999) A role for norepinephrine in stress-induced cognitive deficits: alpha-1-adrenoceptor mediation in the prefrontal cortex. Biol Psychiatry 46:1266-1274
17. Birnbaum SG, Podell DM, Arnsten AF (2000) Noradrenergic alpha-2 receptor agonists reverse working memory deficits induced by the anxiogenic drug, FG7142, in rats. Pharmacol Biochem Behav 67:397-403
18. Bjork JM, Hommer DW, Grant SJ, Danube C (2004) Impulsivity in abstinent alcohol-dependent patients: relation to control subjects and type 1-/type 2-like traits. Alcohol 34:133-150
19. Carli M, Samanin R (2000) The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors. Psychopharmacology (Berl) 149:259-268
20. Charney DS, Heninger GR, Sternberg DE (1982) Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine. Life Sci 30:2033-2041
21. Cole BJ, Robbins TW (1989) Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res 33:165-179
22. de Villiers AS, Russell VA, Sagvolden T, Searson A, Jaffer A, Taljaard JJ (1995) Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder. Neurochem Res 20:427-433
23. Dougherty DM, Bjork JM, Harper RA, Marsh DM, Moeller FG, Mathias CW, Swann AC (2003a) Behavioral impulsivity paradigms: a comparison in hospitalized adolescents with disruptive behavior disorders. J Child Psychol Psychiatry 44:1145-1157
24. Dougherty DM, Bjork JM, Moeller FG, Harper RA, Marsh DM, Mathias CW, Swann AC (2003b) Familial transmission of continuous performance test behavior: attentional and impulsive response characteristics. J Gen Psychol 130:5-21
25. Dougherty DM, Mathias CW, Marsh DM, Papageorgiou TD, Swann AC, Moeller FG (2004) Laboratory-measured behavioral impulsivity relates to suicide attempt history. Suicide and Life-Threatening Behavior 34:374-385
26. Doyle AE, Wozniak J, Wilens TE, Henin A, Seidman LJ, Petty C, Fried R, Gross LM, Faraone SV, Biederman J (2009) Neurocognitive impairment in unaffected siblings of youth with bipolar disorder. Psychol Med 39:1253-1263
27. Dzung LA, Funk D, Harding S, Juzytsch W, Fletcher PJ (2009) The role of noradrenaline and 5-hydroxytryptamine in yohimbine-induced increases in alcohol-seeking in rats. Psychopharmacology (Berl) 204:477-488
28. Economidou D, Theobald DE, Robbins TW, Everitt BJ, Dalley JW (2012) Norepinephrine and dopamine modulate impulsivity on the five-choice serial reaction time task through opponent actions in the shell and core sub-regions of the nucleus accumbens. Neuropsychopharmacology. doi: 10.1038/npp.2012.53
29. Evenden J (2000) Varieties of impulsivity. Psychopharmacol 146:348-361
30. Fernando AB, Economidou D, Theobald DE, Zou MF, Newman AH, Spoelder M, Caprioli D, Moreno M, Hipolito L, Aspinall AT, Robbins TW, Dalley JW (2012) Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists. Psychopharmacology (Berl) 219:341-352
31. Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, Sahakian BJ, Robbins TW, Bullmore ET, Hollander E (2010) Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology 35:591-604
32. First MB, Spitzer RL, Gibbon M, Williams JB (1996) Structured clinical interview for DSM-IV Axis I disorders Patient Edition. Biometrics Research Institute, New York State Psychiatric Institute, New York
33. Fitzgerald PJ (2011) A neurochemical yin and yang: does serotonin activate and norepinephrine deactivate the prefrontal cortex? Psychopharmacology (Berl) 213:171-182
34. Fukuda M, Hata A, Niwa S, Hiramatsu K, Honda H, Nakagome K, Iwanami A (1996) Plasma vanillylmandelic acid level as an index of psychological stress response in normal subjects. Psychiatry Res 63:7-16
35. Goddard AW, Charney DS, Germine M, Woods SW, Heninger GR, Krystal JH, Goodman WK, Price LH (1995) Effects of tryptophan depletion on responses to yohimbine in healthy human subjects. Biol Psychiatry 38:74-85
36. Green DM, Swets JA (1966) Signal detection theory and psychophysics. Wiley, New York
37. Gurguis GN, Uhde TW (1990) Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls. Psychoneuroendocrinology 15:217-224
38. Kalsner S, Abdali SA (2001) Rate-independent inhibition by norepinephrine of 5-HT release from the somadendritic region of serotonergic neurons. Brain Res Bull 55:761-765
39. Lane SD, Cherek DR, Rhoades HM, Pietras CJ, Tcheremissine OV (2003) Relationships among laboratory and psychometric measures of impulsivity: implications in substance abuse and dependence. Addictive Disorders and Their Treat 2:33-40
40. Li GY, Ueki H, Kawashima T, Sugataka K, Muraoka T, Yamada S (2004) Involvement of the noradrenergic system in performance on a continuous task requiring effortful attention. Neuropsychobiology 50:336-340
41. Liu YP, Lin YL, Chuang CH, Kao YC, Chang ST, Tung CS (2009) Alpha adrenergic modulation on effects of norepinephrine transporter inhibitor reboxetine in five-choice serial reaction time task. J Biomed Sci 16:72
42. Ma CL, Arnsten AF, Li BM (2005) Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys. Biol Psychiatry 57:192-195
43. Maas JW, Landis DH (1968) In vivo studies of the metabolism of norepinephrine in the central nervous system. J Pharmacol Exp Ther 163:147-162
44. Maas JW, Hattox SE, Greene NM, Landis DH (1979) 3-Methoxy-4- hydroxyphenethyleneglycol production by human brain in vivo. Science 205:1025-1027
45. Malloy-Diniz LF, Neves FS, de Moraes PH, De Marco LA, Romano-Silva MA, Krebs MO, Correa H (2011) The 5-HTTLPR polymorphism, impulsivity and suicide behavior in euthymic bipolar patients. J Affect Disord 133:221-226
46. Mantsch JR, Weyer A, Vranjkovic O, Beyer CE, Baker DA, Caretta H (2010) Involvement of noradrenergic neurotransmission in the stress- but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for beta-2 adrenergic receptors. Neuropsychopharmacology 35:2165-2178
47. Millan MJ, Newman-Tancredi A, Audinot V, Cussac D, Lejeune F, Nicolas JP, Coge F, Galizzi JP, Boutin JA, Rivet JM, Dekeyne A, Gobert A (2000) Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states. Synapse 35:79-95
48. Mizuki Y, Suetsugi M, Ushijima I, Yamada M (1996) Differential effects of noradrenergic drugs on anxiety and arousal in healthy volunteers with high and low anxiety. Prog Neuropsychopharmacol Biol Psychiatry 20:1353-1367
49. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC (2001) Psychiatric aspects of impulsivity. Am J Psychiatry 158:1783-1793
50. Otte C, Neylan TC, Pole N, Metzler T, Best S, Henn-Haase C, Yehuda R, Marmar CR (2005) Association between childhood trauma and catecholamine response to psychological stress in police academy recruits. Biol Psychiatry 57:27-32
51. Owen JC, Whitton PS (2003) Reboxetine modulates norepinephrine efflux in the frontal cortex of the freely moving rat: the involvement of alpha 2 and 5-HT1A receptors. Neurosci Lett 348:171-174
52. Paterson NE, Wetzler C, Hackett A, Hanania T (2012) Impulsive action and impulsive choice are mediated by distinct neuropharmacological substrates in rat. Int J Neuropsychopharmacol 15:1473-1487
53. Peskind ER, Veith RC, Dorsa DM, Gumbrecht G, Raskind MA (1989) Yohimbine increases cerebrospinal fluid and plasma norepinephrine but not arginine vasopressin in humans. Neuroendocrinology 50:286-291
54. Powell SB, Palomo J, Carasso BS, Bakshi VP, Geyer MA (2005) Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors. Psychopharmacology (Berl) 180:491-500
55. Price LH, Charney DS, Heninger GR (1984) Three cases of manic symptoms following yohimbine administration. Am J Psychiatry 141:1267-1268
56. Reynolds B, Penfold RB, Patak M (2008) Dimensions of impulsive behavior in adolescents: laboratory behavioral assessments. Exp Clin Psychopharmacol 16:124-131
57. Riba J, Rodriguez-Fornells A, Morte A, Munte TF, Barbanoj MJ (2005) Noradrenergic stimulation enhances human action monitoring. J Neurosci 25:4370-4374
58. Roychowdhury S, Pena-Contreras Z, Tam J, Yadlapalli A, Dinh L, Nichols JA, Basu D, Atzori M (2012) alpha(2)- and beta-adrenoceptors involvement in nortriptyline modulation of auditory sustained attention and impulsivity. Psychopharmacology (Berl) 222:237-245
59. Scheinin M, Chang W, Jimerson DC, Linnoila M (1983) Measurement of 3-methoxy-4-hydroxyphenylglycol in human plasma with high performance liquid chromatography using electrochemical detection. Anal Biochem 132:165-170
60. Schepis TS, McFetridge A, Chaplin TM, Sinha R, Krishnan-Sarin S (2011) A pilot examination of stress-related changes in impulsivity and risk taking as related to smoking status and cessation outcome in adolescents. Nicotine Tob Res 13:611-615
61. Soltis RP, Cook JC, Gregg AE, Sanders BJ (1997) Interaction of GABA and excitatory amino acids in the basolateral amygdala: role in cardiovascular regulation. J Neurosci 17:9367-9374
62. Spitzer RL, Endicott J (1978) Schedule for affective disorders and schizophrenia: change version. Biometrics Research, New York State Psychiatric Institute, New York
63. Stanford MS, Mathias CW, Dougherty DM, Lake SL, Anderson NE, Patton JH (2009) Fifty years of the Barratt Impulsiveness Scale: an update and review. Personal Individ Differ 47:385-395
64. Sun H, Green TA, Theobald DE, Birnbaum SG, Graham DL, Zeeb FD, Nestler EJ, Winstanley CA (2010) Yohimbine increases impulsivity through activation of cAMP response element binding in the orbitofrontal cortex. Biol Psychiatry 67:649-656
65. Sun H, Cocker PJ, Zeeb FD, Winstanley CA (2012) Chronic atomoxetine treatment during adolescence decreases impulsive choice, but not impulsive action, in adult rats and alters markers of synaptic plasticity in the orbitofrontal cortex. Psychopharmacology (Berl) 219:285-301
66. Swann AC, Maas JW, Hattox SE, Landis DH (1980) Catecholamine metabolites in human plasma as indices of brain function: effects of debrisoquin. Life Sci 27:1857-1862
67. Swann AC, Koslow SH, Katz MM, Maas JW, Javaid J, Secunda SK, Robins E (1987) Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. Arch Gen Psychiatry 44:345-354
68. Swann AC, Bjork JM, Moeller FG, Dougherty DM (2002) Two models of impulsivity: relationship to personality traits and psychopathology. Biol Psychiatry 51:988-994
69. Swann AC, Pazzaglia P, Nicholls A, Dougherty DM, Moeller FG (2003) Impulsivity and phase of illness in bipolar disorder. J Affect Disord 73:105-111
70. Swann AC, Birnbaum D, Jagar AA, Dougherty DM, Moeller FG (2005a) Acute yohimbine increases laboratory-measured impulsivity in normal subjects. Biol Psychiatry 57:1209-1211
71. Swann AC, Dougherty DM, Pazzaglia PJ, Pham M, Steinberg JL, Moeller FG (2005b) Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am J Psychiatry 162:1680-1687
72. Swann AC, Lijffijt M, Lane SD, Steinberg JL, Moeller FG (2009) Trait impulsivity and response inhibition in antisocial personality disorder. J Psychiatr Res 43:1057-1063
73. Swann AC, Lijffijt M, Lane SD, Kjome KL, Steinberg JL, Moeller FG (2011) Criminal conviction, impulsivity, and course of illness in bipolar disorder. Bipolar Disord 13:173-181
74. Szabo B, Urban R (1995) Mechanism of sympathoinhibition by imidazolines. Ann N Y Acad Sci 763:552-565
75. Szemeredi K, Komoly S, Kopin IJ, Bagdy G, Keiser HR, Goldstein DS (1991) Simultaneous measurement of plasma and brain extracellular fluid concentrations of catechols after yohimbine administration in rats. Brain Res 542:8-14
76. Tibirica E, Feldman J, Mermet C, Gonon F, Bousquet P (1991) An imidazoline-specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan. J Pharmacol Exp Ther 256:606-613
77. Torregrossa MM, Xie M, Taylor JR (2012) Chronic corticosterone exposure during adolescence reduces impulsive action but increases impulsive choice and sensitivity to yohimbine in male Sprague-Dawley rats. Neuropsychopharmacology 37:1656-1670
78. van Kammen DP, Murphy DL (1975) Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 44:215-224
79. Vythilingam M, Anderson GM, Owens MJ, Halaszynski TM, Bremner JD, Carpenter LL, Heninger GR, Nemeroff CB, Charney DS (2000) Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone. J Clin Endocrinol Metab 85:4138-4145
80. Winstanley CA (2011) The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol 164:1301-1321. doi: 10.1111/j.1476-5381.2011.01323.x